This inventor holds 1 USPTO granted patent. Top assignees: Kumamoto University, Nihon Shokuhin Kako Co., Ltd.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:


Years Active: 2025
Title: Ryoma Yokoyama: Innovator in Drug Delivery Systems
Introduction
Ryoma Yokoyama is a notable inventor based in Kumamoto, Japan. He has made significant contributions to the field of drug delivery systems, particularly in developing substances that can effectively penetrate the blood-brain barrier. His innovative work aims to enhance the delivery of pharmaceuticals to the brain, addressing critical medical challenges.
Latest Patents
Yokoyama holds a patent for a brain-penetrating ligand and drug carrier. This exemplary substance is designed to permeate the blood-brain barrier, showcasing its ability to penetrate into the brain. The patent also includes the use of this substance as a drug carrier for delivering medications into the brain. Additionally, it features lactose-modified cyclodextrin or dendrimer/glucuronyl glucosyl-cyclodextrin, which also demonstrate the capability to cross the blood-brain barrier. The pharmaceutical composition described in the patent comprises these components along with a drug, providing a promising avenue for effective brain-targeted therapies.
Career Highlights
Throughout his career, Ryoma Yokoyama has been associated with prestigious institutions such as Kumamoto University and Nihon Shokuhin Kako Co., Ltd. His work in these organizations has allowed him to collaborate with other experts in the field and contribute to advancements in pharmaceutical sciences.
Collaborations
Yokoyama has worked alongside notable colleagues, including Keiichi Motoyama and Taishi Higashi. Their collaborative efforts have furthered research and development in drug delivery systems, enhancing the potential for innovative treatments.
Conclusion
Ryoma Yokoyama's contributions to the field of drug delivery, particularly through his patent for a brain-penetrating ligand and drug carrier, highlight his role as an innovator in pharmaceutical sciences. His work continues to pave the way for advancements in medical treatments targeting the brain.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile